Sign In
Buy AMPH
$18.12
-0.330 (-1.79%)
At Close: Jun 03, 2026
Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates
06:31pm, Monday, 15'th Mar 2021
Amphastar (AMPH) delivered earnings and revenue surprises of 14.29% and 7.42%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Amphastar Pharmaceuticals Q4 Earnings
05:00pm, Monday, 15'th Mar 2021
Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 128.57% year over year to $0.16, wh
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020
04:05pm, Monday, 15'th Mar 2021
Reports Net Revenues of $95.9 Million for the Three Months Ended December 31, 2020 Reports Net Revenues of $95.9 Million for the Three Months Ended December 31, 2020
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021
05:39pm, Monday, 08'th Mar 2021
RANCHO CUCAMONGA, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its fourth quarter of 2020 ended Decembe
Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference
06:01am, Friday, 26'th Feb 2021
RANCHO CUCAMONGA, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, V.P of Corporate Communications and HR,
Amphastar Announces Approval for Glucagon for Injection Kit, 1mg
06:00am, Tuesday, 29'th Dec 2020
RANCHO CUCAMONGA, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) has approved its Abbrevia
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q3 2020 Results - Earnings Call Transcript
10:49pm, Sunday, 08'th Nov 2020
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q3 2020 Results - Earnings Call Transcript
Amphastar Pharmaceuticals' (AMPH) Management on Q3 2020 Results - Quick Version Earnings Call Transcript
02:05pm, Friday, 06'th Nov 2020
Amphastar Pharmaceuticals' (AMPH) Management on Q3 2020 Results - Quick Version Earnings Call Transcript
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2020
06:50am, Friday, 06'th Nov 2020
Reports Net Revenues of $83.4 Million for the Three Months Ended September 30, 2020 Reports Net Revenues of $83.4 Million for the Three Months Ended September 30, 2020
The Global Preclinical Respiration and Inhalation Lab Equipment Market will grow by $ 2.26 mn during 2020-2024
Amphastar Pharmaceuticals (AMPH) Presents at Wells Fargo Securities 2020 Virtual Healthcare Conference - Slideshow
05:42pm, Friday, 11'th Sep 2020
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with this event..
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020
08:05pm, Thursday, 06'th Aug 2020
Reports Net Revenues of $85.8 Million for the Three Months Ended June 30, 2020RANCHO CUCAMONGA, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar�
Amphastar Pharmaceuticals's Earnings: A Preview
04:18pm, Wednesday, 05'th Aug 2020
On Thursday, August 06, Amphastar Pharmaceuticals (NASDAQ: AMPH) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.Earnings an
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Short Interest Down 6.7% in July
03:44am, Tuesday, 04'th Aug 2020
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) was the target of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 2,630,000 shares, a dec
Here's What Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Shareholder Ownership Structure Looks Like
12:05pm, Monday, 03'rd Aug 2020
If you want to know who really controls Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), then you'll have to look at the...
